GlassScriptPhysician profile
Jordan Cormack
NPI 1548890247
$2,674.72
in general payments reported to CMS, 2019-2025
7 companies · $416 in 2025
The $416 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $524 · 2024: $1,735 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,661 · Travel and Lodging: $1,014.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,661.00 |
| Travel and Lodging | $1,013.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,974.87 | 2024-2025 | Symplicity G3, Aurora Ev-Icd Mri Surescan, Ffrangio |
| Janssen Pharmaceuticals, INC | $290.88 | 2023 | Xarelto |
| Abiomed | $149.99 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $109.20 | 2023 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $81.46 | 2023 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $39.15 | 2023-2025 | Camzyos, Eliquis |
| Csl Behring | $29.17 | 2023 | Kcentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Cormack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.